Abstract 3281: The Prognostic Characteristics of Cardiopulmonary Exercise Testing in Caucasian and African-American Patients with Heart Failure

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Ross Arena ◽  
Jonathan Myers ◽  
Mary Ann Peberdy ◽  
Daniel Bensimhon ◽  
Paul Chase ◽  
...  

Introduction: Peak oxygen consumption (VO 2 ) and the minute ventilation (VE)/carbon dioxide production (VCO 2 ) slope are prognostically important in the heart failure (HF) population. Hypothesis: We assessed the hypothesis that the prognostic characteristics of peak VO 2 and the VE/VCO 2 slope would be comparable between Caucasian and African-American subjects with HF. Methods: Four hundred and ninety one HF patients (339 Caucasian/152 African-American) underwent cardiopulmonary exercise testing and were tracked for major cardiac events for three years. Results: The following comparisons are reported as Caucasian vs. African-American subgroups, respectively. Age (56.7 ±14.4 vs. 47.1 ±13.4 years, p<0.001) and ejection fraction (30.6 ±12.9 vs. 25.2 ±11.7%, p<0.001) were significantly lower in the African-American subgroup. Peak VO 2 (15.7 ± 5.6 vs. 14.8 ± 5.7 mlO 2 ·kg −1 ·min −1 , p<0.11) and the VE/VCO 2 slope (35.4 ±9.8 vs. 36.8 ±9.7, p=0.15) were not significantly different. There were 44 (annual event rate: 8.3%) major cardiac events (25 deaths/14 heart transplants/5 left ventricular assist device implantations) in the Caucasian subgroup and 25 (annual event rate: 10.1%) major cardiac events (18 deaths/5 heart transplants/2 left ventricular assist device implantations) in the African-American subgroup. Receiver operating characteristic (ROC) curve analysis and hazard ratios for exercise test variables are listed in Table 1 . Peak VO 2 and the VE/VCO 2 slope were prognostically significant in both subgroups. Conclusions: Despite differences in baseline characteristics between Caucasian and African-American subjects, the optimal prognostic threshold values of established exercise testing variables were similar. The VE/VCO 2 slope was the superior prognostic marker in both subgroups. While, peak VO 2 was prognostically significant in Caucasian and African-American subjects, its value was diminished in the latter subgroup.

2019 ◽  
Vol 5 (2) ◽  
pp. 77
Author(s):  
Athanasios Tasoulis ◽  
Georgios Tzanis ◽  
Ioannis Vasileiadis ◽  
Stavros Dimopoulos ◽  
Eleftherios Karatzanos ◽  
...  

Background: Patients with heart failure (HF) suffer from ventilatory abnormalities that are related to poor prognosis.Aim: The aim of the study was to investigate the respiratory drive in HF patients early after left ventricular assist device (LVAD) implantation. Methods: We enrolled eight HF patients after LVAD (HeartMate II) implantation and 8 patients with advanced HF (control group). Patients were evaluated with cardiopulmonary exercise testing, respiratory function tests and transthoracic echocardiographic examination at 1, 3 and 6 months. Respiratory drive was estimated by the mouth occlusion pressure-P0.1 and the P0.1/Pimax ratio.Results: LVAD patients at 1, 3 and 6 months after implantation had significantly improved P0.1/Pimax% ratio (4.17±0.43 vs 3.29±1.0 vs 2.56±0.35 respectively,p<0.01) as well as significantly increased in Pimax. No changes where observed in the HF control group. A significant decrease in LVEDD, LVESD and an improvement in LVEF is also observed during follow up.Conclusions: Our results imply LVAD implantantion induces a progressive and significant improvement of respiratory drive and Left ventricle reverse remodeling during a 6 month follow-up period.


2019 ◽  
Vol 2019 ◽  
pp. 1-6
Author(s):  
Rabih Tabet ◽  
Najib Nassani ◽  
Boutros Karam ◽  
Youssef Shammaa ◽  
Philippe Akhrass ◽  
...  

Background. To date, video capsule endoscopy (VCE) is still contraindicated by the FDA and the main manufacturers of Cardiac Implantable Electronic Devices (CIED) in patients with CIED, given a theoretical electromagnetic interference and possible device malfunction. Objectives. The objective of this study was to assess the safety profile and efficacy of VCE in patients with implantable cardiac devices through analyzing the risk of mutual interference. Methods. A systematic review of PubMed, Web of Science, and Embase databases was conducted. Peer-reviewed original articles, published in the English language and containing “capsule endoscopy” AND “pacemaker”, “defibrillator” OR “left ventricular assist device” as keywords, were selected. Studies performed in vitro, isolated case reports, and abstracts/posters were excluded. Results. A total of 735 VCE procedures were performed in patients with cardiac devices in various clinical settings. Cardiac events were not seen in any case. Interference on capsule images transmission was noted in 5 cases (left ventricular assist device (LVAD)) where few images were lost when the capsule was closest to the device. Finally, interference between capsule and telemetry leads was noted in 6 cases (4 Permanent Pacemakers (PPM), 2 Implantable Cardioverter-Defibrillator (ICD)) leading to image artifacts. Discussion. Adverse cardiac events were not seen in any study. Loss of images occurred when the VCE was in proximity to the device (only with LVAD) or after telemetry leads installation without affecting the completion rate and diagnostic yield of VCE. Conclusion. VCE is safe and remains efficient in patients with cardiac devices. If cardiac monitoring is required, wired systems are preferable.


Sign in / Sign up

Export Citation Format

Share Document